Spring til hovednavigation Spring til søgning Spring til hovedindhold

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments

Bernardo Sousa-Pinto, Jean Bousquet*, Rafael José Vieira, Holger J Schünemann, Torsten Zuberbier, Antonio Bognanni, Alkis Togias, Boleslaw Samolinski, Arunas Valiulis, Sian Williams, Anna Bedbrook, Wienczyslawa Czarlewski, Maria Jose Torres, Mohamed H Shamji, Mário Morais-Almeida, G Walter Canonica, Leticia de Las Vecillas, Mark S Dykewicz, Cristina Jacomelli, Ludger KlimekLucas Leemann, Olga Lourenço, Yuliia Palamarchuk, Nikolaos G Papadopoulos, Ana Margarida Pereira, Marine Savouré, Sanna K Toppila-Salmi, Maria Teresa Ventura, Juan José Yepes-Nuñez, Alvaro A Cruz, Giorgio Ciprandi, Bilun Gemicioglu, Mattia Giovannini, Brigita Gradauskiene, Tuomas Jartti, Miloš Jeseňák, Piotr Kuna, Violeta Kvedariene, Désirée E Larenas-Linnemann, Amir Ha Latiff, Yousser Mohammad, Ken Ohta, Padukudru A Mahesh, Isabella Pali-Schöll, Oliver Pfaar, Frederico S Regateiro, Nicolas Roche, Luís Taborda-Barata, Charlotte Suppli Ulrik, Marylin Valentin Rostan, Giovanni Viegi, Luo Zhang, Tari Haahtela, Ivan Cherrez-Ojeda, Juan Carlos Ivancevich, Nikolai Khaltaev, Arzu Yorgancioglu, Baharudin Abdullah, Mona Al-Ahmad, Maryam Ali Al-Nesf, Rita Amaral, Julijana Asllani, Karl-C Bergmann, Jonathan A Bernstein, Michael S Blaiss, Fulvio Braido, Paulo Camargos, Pedro Carreiro-Martins, Thomas Casale, Lorenzo Cecchi, Alessandro Fiocchi, Antonio F M Giuliano, George Christoff, Ieva Cirule, Jaime Correia de Sousa, Elisio M Costa, Stefano Del Giacco, Philippe Devillier, Dejan Dokic, Elham Hossny, Tomohisa Iinuma, Carla Irani, Zhanat Ispayeva, Kaja Julge, Igor Kaidashev, Kazi S Bennoor, Helga Kraxner, Inger Kull, Marek Kulus, Maciej Kupczyk, Andriy Kurchenko, Stefania La Grutta, Neven Miculinic, Lan Le Thi Tuyet, Michael Makris, Branislava Milenkovic, Sang Min Lee, Stephen Montefort, Andre Moreira, Joaquim Mullol, Rachel Nadif, Alla Nakonechna, Hugo E Neffen, Marek Niedoszytko, Dieudonné Nyembue, Robyn E O'Hehir, Ismail Ogulur, Yoshitaka Okamoto, Heidi Olze, Oscar Palomares, Petr Panzner, Vincenzo Patella, Ruby Pawankar, Constantinos Pitsios, Todor A Popov, Francesca Puggioni, Santiago Quirce, Agné Ramonaité, Marysia Recto, Maria Susana Repka-Ramirez, Graham Roberts, Karla Robles-Velasco, Menachem Rottem, Marianella Salapatas, Joaquin Sastre, Nicola Scichilone, Juan-Carlos Sisul, Dirceu Solé, Manuel E Soto-Martinez, Milan Sova, Pongsakorn Tantilipikorn, Ana Todo-Bom, Vladyslav Tsaryk, Ioanna Tsiligianni, Marilyn Urrutia-Pereira, Erkka Valovirta, Tuula Vasankari, Dana Wallace, De Yun Wang, Margitta Worm, Osman M Yusuf, Mihaela Zidarn, Sara Gil-Mata, Manuel Marques-Cruz, Bassam Mahboub, Ignacio J Ansotegui, Antonino Romano, Werner Aberer, Maria Cristina Artesani, Elena Azzolini, Bruno Barreto, Joan Bartra, Sven Becker, Bianca Beghe, Attilio Boner, Ewa Borowiack, Jacques Bouchard, Melisande Bourgoin-Heck, Luisa Brussino, Roland Buhl, José Antonio Castillo-Vizuete, Denis Charpin, Niels H Chavannes, Marta Chełmińska, Lei Cheng, Ekaterine Chkhartishvili, Seong H Cho, Herberto Jose Chong-Neto, Deepa Choudhury, Derek K Chu, Cemal Cingi, Enrico Compalati, Raquel Albuquerque Costa, Olga Mariana Cunha, Biljana Cvetkovski, Victoria Cardona-Dahl, Gennaro D'Amato, Janet Davies, Danilo Di Bona, Sandra N Gonzalez Diaz, Maria V Dimou, Maria Doulaptsi, Renato Ferreira-da-Silva, Radoslaw Gawlik, Mario Calvo-Gil, Ozlem Goksel, Maximiliano R Gómez, Maia Gotua, Christos Grigoreas, Ineta Grisle, Maria Antonieta Guzman, Rachel House Tan, Michael Hyland, Despo Ierodiakonou, Aspasia Karavelia, Paul Keith, Marta Kisiel, Tanja Soklic Kosak, Mitja Kosnik, Ilgim Vardaloglu Koyuncu, Vicky Kritikos, Justyna Litynska, Carlo Lombardi, Gilles Louis, Matteo Martini, Cem Meço, Eris Mesonjesi, Florin Mihaltan, Marcin Moniuszko, Robert N Naclerio, Kari C Nadeau, Sophia Neisinger, Markus Ollert, Michal Ordak, Giovanni Paoletti, Hae-Sim Park, Elena Parmelli, Edgar Arturo Perdomo-Flores, José Miguel Fuentes Pérez, Nhan Pham-Thi, Emmanuel Prokopakis, Inês Ribeiro-Vaz, Giovanni Rolla, Jan Romantowski, Philippe Rombaux, Philip W Rouadi, Maia Rukhadze, Dermot Ryan, Ewelina Sadowska, Daiju Sakurai, Laila Salameh, Faradiba Serpa Sarquis, Elie Serrano, Jane Da Silva, Michael Soyka, Krzysztof Specjalski, Vesna Tomic-Spiric, Katarina Stevanovic, Abirami Subramaniam, Maria Do Ceu Teixeira, Tuuli Thomander, Martina Vachova, Marianne van Hage, Pakit Vichyanond, Martin Wagenmann, Fanny Wai San Ko, Pascal Werminghaus, Paraskevi Vicky Xepapadaki, Yi-Kui Xiang, Qintai Yang, Daniela Rivero Yeverino, Jaron Zuberbier, João A Fonseca

*Corresponding author af dette arbejde

Abstract

BACKGROUND: Allergic rhinitis (AR) impacts quality of life, work and school productivity. Over the last years, an important body of evidence resulting from mHealth data has led to a better understanding of AR. Such advances have motivated an EAACI-endorsed update of the Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines (ARIA 2024-2025). This manuscript presents the ARIA 2024-2025 recommendations for intranasal treatments, one of the mainstays for AR management.

METHODS: The ARIA 2024-2025 guideline panel issued recommendations following the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) evidence-to-decision framework. Several sources of evidence were used to inform panel judgments and recommendations, including systematic reviews, evaluation of mHealth and pharmacovigilance data, as well as a survey of experts on costs.

RESULTS: Eleven guideline questions concerning intranasal treatments for AR were prioritized, leading to recommendations. Overall, these questions concern the choice between different classes of intranasal medications-most notably, intranasal corticosteroids (INCS), antihistamines (INAH), fixed combinations of INAH+INCS and decongestants-or between different individual medications within each class. Four questions had not been evaluated in previous ARIA guidelines, while for the other three there was a change in the strength or directionality of recommendations. Overall, recommendations point to the suggested use of INAH+INCS over INAH or INCS and INCS over INAH.

CONCLUSION: This ARIA 2024-2025 article supports patients, their caregivers, and healthcare professionals in choosing an intranasal treatment. However, decisions on AR treatment should consider the clinical variability of the disease, patients' values, and the affordability of medications.

OriginalsprogEngelsk
TidsskriftAllergy
Vol/bind81
Udgave nummer4
Sider (fra-til)954-976
Antal sider23
ISSN0105-4538
DOI
StatusUdgivet - apr. 2026

Fingeraftryk

Dyk ned i forskningsemnerne om 'Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part I-Guidelines on Intranasal Treatments'. Sammen danner de et unikt fingeraftryk.

Citationsformater